Concordix is a patented nutraceutical delivery technology—protected by an extensive global patent portfolio—owned and developed by Vitux AS, a Nordic contract development and manufacturing organization (CDMO). Produced in facilities in Andenes, Norway, and Windsor, Canada, Concordix is designed to transform supplements from inert dosing vehicles into intelligent, body-synergistic delivery systems.